At the Intersection of 2 Pandemics: The Impact of COVID-19 on HIV
A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.
HIV/AIDS
HIV/AIDS
-
-
Fighting the Syndemic: Addressing Opioid Use Disorder and Decreasing HIV Go Hand-in- Hand
Structural concerns, racial and socioeconomic issues, and state- and federal-level policy present challenges when trying to address the intersecting epidemics of opioid use disorder and HIV. -
Women Living With HIV Require Better Mental Health Diagnostics and Interventions
In a narrative review, researchers described various mental health interventions, and their feasibility and outcomes for WLWH. -
Understanding the Oncogenic Role of HIV in Burkitt Lymphoma
While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady. -
Neurocognitive Conditions Among People Living With HIV
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
Latest News
Exposure to HIV In Utero May Lead to Poor Neurodevelopment in Children
Investigators assessed neurodevelopment outcomes among uninfected children exposed to HIV infection and different maternal antiretroviral therapy regimens.
Prevalence of Comorbid Conditions in Patients With vs Without HIV Infection
Researchers evaluated the prevalence of comorbid conditions among patients with vs without HIV infection.
Lenacapavir Reduces Viral Load in Multidrug-Resistant HIV-1 Infection
Patients with multidrug-resistant HIV-1 infection receiving the capsid inhibitor lenacapavir have a greater reduction in viral load than those receiving placebo.
Fluconazole vs Other Antifungals for Esophageal Candidiasis in Patients With HIV
In this meta-analysis, researchers assessed the safety and efficacy of fluconazole compared with alternative antifungal agents for the treatment of esophageal candidiasis.
Outcomes, Safety of Weight-Based Bedaquiline in Children With Multidrug-Resistant Tuberculosis
Researchers assessed the pharmacokinetic profile and safety of weight-based bedaquiline among children with multidrug-resistant tuberculosis.
Injectable Cabotegravir: Effective, May Overcome Challenges of Daily HIV Pre-Exposure Prophylaxis for Women
Researchers compared the safety and efficacy of injectable cabotegravir vs oral tenofovir diphosphate plus emtricitabine for the prevention of HIV infection among women.
Perinatal Outcomes Similar Between Different Protease Inhibitor-Based Antiretroviral Regimens
Investigators assessed whether treatment with protease inhibitor-based antiretroviral therapy during pregnancy increases the risk for poor perinatal outcomes among women with HIV infection.
Robust Immunity After COVID-19 Vaccination in People With HIV With High CD4 Count
Researchers assessed the relationship between current CD4 T-cell counts and Immunogenicity after COVID-19 vaccination among people with HIV infection.
Computerized Cognitive Training May Help HIV-Associated Neurocognitive Disorder
Researchers assessed whether computerized cognitive training programs were associated with improvements in overall cognitive and daily function in patients with HIV infection.
Automated Dual Stain Cytology Highly Sensitive for Anal Precancer in Men With HIV
Researchers conducted a cross-sectional analysis that compared the performance of automated dual stain (DS) cytology with manual DS cytology for the detection of anal precancer among men who have sex with men living with HIV infection.
Feasibility of Metatranscriptomics for Pneumonia Surveillance in Adults With HIV
Researchers evaluated the use of metatranscriptomic RNA sequencing for the epidemiologic surveillance of pneumonia pathogens in patients with HIV infection.
How Can Mental Health Affect HIV Prevention Outcomes?
Mental health struggles may play a larger role in approaching HIV prevention than patients realize. How do symptoms of depression and anxiety affect HIV risk behaviors, and how can health care professionals educate patients and increase prevention?
Multidrug-Class Antiretroviral Regimens Associated With Incident Atrial Fibrillation
Researchers conducted a study to determine risk factors associated with incident atrial fibrillation in patients with HIV infection.
Glucocorticoids in Hair May Be a Marker for HIV Disease Progression
Researchers assessed the relationship between long-term exposure to glucocorticoids and HIV disease progression.
Carriage of Extended-Spectrum β-lactamase-Producing Enterobacterales Associated With Number of Sexual Partners
Researchers conducted a study to determine whether the risk for extended-spectrum -lactamase-producing enterobacterales is associated with number of sexual partners and increased sexual activity.
Risk for Incident Liver Damage in Patients With HIV on Antiretroviral Therapy
Researchers assessed the risk for liver damage among patients with HIV-1 monoinfection receiving antiretroviral therapy.
Diagnostic Accuracy of Point-of-Care HIV Viral Load Tests vs Laboratory-Based Assays
In this meta-analysis, researched compared the diagnostic accuracy point-of-care HIV RNA viral load tests with laboratory-based assays to detect antiretroviral therapy treatment failure in patients with HIV infection.
Dihydroartemisinin/Piperaquine With Dolutegravir-Based Antiretroviral Therapy Safe During Pregnancy
Researchers conducted a study to assess the pharmacokinetics and effect of dolutegravir-based antiretroviral therapy in combination with dihydroartemisinin/piperaquine in women with HIV infection who were pregnant.
Kidney Impairment in Older vs Younger Patients on HIV Pre-Exposure Prophylaxis
In this meta-analysis, researchers evaluated the risk for kidney function impairment in patients receiving tenofovir disoproxil fumarate-based pre-exposure prophylaxis against HIV infection.
Cabenuva Approval Expanded to Include Adolescents With HIV
The expanded approval was supported by data from studies in the adult population and by data from an interim analysis of the phase 1/2 MOCHA study.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in HIV/AIDS
Loading... 
Loading...